Apical Hypertrophic Cardiomyopathy

This is a specific type of heart muscle disease called hypertrophic cardiomyopathy. It affects the bottom part (apex) of the heart's main pumping chamber (left ventricle). It causes the muscle wall at the bottom to thicken. This thickening can sometimes make the heart beat irregularly or cause chest pain or fainting. It's sometimes called 'ace of spades' heart disease because of a specific shape seen on an EKG test.

Condition

What people with Apical Hypertrophic Cardiomyopathy report

Every report comes from a Lived member, sent anonymously.

Have you tried Toprol-XL / Lopressor (Metoprolol) for Apical Hypertrophic Cardiomyopathy?

NameHow it went

About Apical Hypertrophic Cardiomyopathy

What It Is

Apical hypertrophic cardiomyopathy is a form of hypertrophic cardiomyopathy (HCM), a condition in which the heart muscle becomes abnormally thick without another cause such as long-standing high blood pressure or a valve problem. In the apical form, the thickening is concentrated at the tip (apex) of the left ventricle, the heart's main pumping chamber. A thick, stiff apex leaves less room for blood and relaxes less easily between beats, so the chamber fills less freely. Many people have few or no symptoms, and the condition is often found because an electrocardiogram (ECG), a tracing of the heart's electrical activity, shows unusually deep T-wave inversions (the wave marking each heartbeat's recovery phase points downward instead of up). When symptoms do occur, chest pain is the most common, followed by palpitations, breathlessness with exertion and, less often, fainting. Because the chest pain and ECG changes can resemble a heart attack, apical HCM is sometimes first suspected during an urgent heart workup. Apical HCM is much more common in people of East Asian descent, where it makes up roughly a fifth to more than a third of HCM cases in some countries, compared with under a tenth in Europe and North America. It is diagnosed more often in men, usually in midlife.

Causes & Risk Factors

HCM is usually caused by variants in genes for the proteins that make heart muscle contract, and these variants can be passed from parent to child. In apical HCM, though, genetic testing finds a disease-causing variant less often than in other forms of HCM (in roughly 13 to 25% of people tested, compared with about a third or more in HCM overall), and fewer people report an affected relative. Researchers do not yet know why the thickening settles at the apex in some people. Inheriting a variant does not mean someone will develop thickening, and severity can differ widely even within one family. Several other conditions can thicken the heart in a similar pattern and need to be ruled out, including long-standing high blood pressure, the heart changes of intensive athletic training, and rare inherited disorders such as Fabry disease, which has its own specific treatment.

How It's Diagnosed

Diagnosis rests on heart imaging. An echocardiogram (an ultrasound of the heart) is the usual first test. Apical HCM is generally diagnosed when the wall at the apex measures 15 millimeters or more and is clearly thicker than the rest of the ventricle, about one and a half times the thickness of the back wall. Clinicians may accept a lower measurement when the ECG and other imaging findings point strongly to the condition. The apex is hard to see well on standard ultrasound, so apical HCM and its complications, such as a small aneurysm (a thinned, bulging area of scarred muscle), can be missed, and a normal standard echocardiogram does not fully rule it out. When suspicion remains, cardiac magnetic resonance imaging (MRI) or an echocardiogram with contrast dye gives a clearer view. MRI can also show scarring (fibrosis), which helps estimate future risk. A heart monitor worn for 24 to 48 hours looks for rhythm problems such as atrial fibrillation, an irregular rhythm of the upper chambers, and short runs of fast beats from the lower chambers. Because chest pain is so common, some people also have a coronary computed tomography (CT) scan or angiogram to check for blocked arteries. The assessment includes a family history covering three generations, and guidelines recommend genetic counseling. If testing finds a disease-causing variant, relatives can be tested for that specific variant. Parents, siblings and children are also offered screening echocardiograms, repeated every 3 to 5 years in adults and every 1 to 2 years in children.

Treatment Options

There are no treatment trials specific to apical HCM, so care follows general HCM guidelines adapted to this form. Treatment aims to ease symptoms, prevent stroke and find the minority of people at risk of dangerous heart rhythms. People without symptoms or risk markers may need regular monitoring rather than medicine. Beta-blockers are usually the first medicine. By slowing the heart rate they give the stiff ventricle more time to fill and lower the heart's oxygen demand, which can ease chest pain and breathlessness, although whether they change long-term outcomes is not known. Verapamil and diltiazem, calcium channel blockers that also slow the heart, are alternatives. Low-dose diuretics (water pills) can relieve breathlessness or fluid buildup, but they are used cautiously because a small, stiff ventricle depends on adequate filling and too much fluid loss can cause low blood pressure. Mavacamten (Camzyos), a newer medicine that reduces how forcefully heart muscle contracts, is approved for obstructive HCM, in which thickened muscle blocks blood leaving the heart. Apical HCM usually does not cause that blockage, so this drug and the septal procedures used for obstructive HCM (which thin the wall between the ventricles) generally do not apply. If atrial fibrillation develops, guidelines recommend a blood thinner for people with HCM, because atrial fibrillation with HCM carries a high risk of clots and stroke on its own. This differs from many other people with atrial fibrillation, whose need for one depends on additional stroke risk factors. Blood thinners are also used after a clot or stroke. An implantable cardioverter-defibrillator (ICD), a small device placed under the skin that can shock the heart out of a dangerous rhythm, is recommended for people who have survived a cardiac arrest or sustained fast rhythm. It is considered for people with major risk markers, such as an apical aneurysm, very marked thickening of the heart wall, extensive scarring on MRI, weakened pumping function, unexplained fainting, or sudden HCM-related death in a close relative. For the few people with severe breathlessness that persists despite medicine, experienced centers can perform apical myectomy, open-heart surgery through the tip of the heart that removes excess muscle to enlarge the chamber. In one large surgical series most people reported feeling better afterward, but the operation is reserved for carefully selected patients. Catheter ablation, which destroys the small area of heart tissue driving an abnormal rhythm, is occasionally used for recurrent rhythm problems.

What to Expect

Many people with apical HCM live for decades with mild or no symptoms. Early studies, mostly from East Asia, suggested a milder course than other forms of HCM, but later, longer studies outside East Asia found outcomes closer to other forms of HCM and survival below that of the general population. The course varies from person to person. Over the years some people develop atrial fibrillation (about 11 to 17% in studies), increasing breathlessness from a stiff heart, or an apical aneurysm, which raises the risk of clots and rhythm problems. Older age, the mixed form with thickening beyond the apex, and these complications are linked with a less favorable outlook, while thickening confined to the apex tends to follow a milder course. Follow-up is lifelong. Guidelines recommend an ECG every 1 to 2 years, an echocardiogram every 1 to 2 years or whenever symptoms change, and a review of sudden-death risk every 1 to 2 years, because the heart can change over time. The deep T waves on the ECG may also change or fade as part of the condition's natural history. Telling new clinicians about the diagnosis helps them interpret an ECG that could otherwise be mistaken for a heart attack. Mild to moderate recreational exercise is encouraged. Decisions about competitive or high-intensity sport are made individually with a cardiologist rather than through blanket bans. People planning a pregnancy benefit from talking with their cardiologist beforehand, since medicines may need review and genetic counseling can be offered.

When to Seek Help

Arrange a cardiology evaluation if an ECG shows deep T-wave inversions without a clear explanation, or if a parent, sibling or child has been diagnosed with HCM. Contact your care team promptly about fainting or near-fainting without a clear cause, new or more frequent palpitations, increasing breathlessness, leg swelling or a drop in how much you can do. These can signal atrial fibrillation, worsening heart function or a higher rhythm risk. Call 911 for severe trouble breathing or breathlessness at rest, which is different from the gradual worsening described above. Call 911 for chest pain that is severe, or chest pain unlike your usual pattern that does not ease after a few minutes of rest. Call 911 for sudden signs of stroke, such as face drooping, arm weakness or trouble speaking. If someone collapses and is unresponsive, call 911 and start cardiopulmonary resuscitation (CPR), using an automated external defibrillator (AED) if one is available.

Questions to Ask Your Doctor

  1. 1.Is my apical HCM the pure or mixed form, and do I have an aneurysm or scarring that changes my risk?
  2. 2.Based on my risk markers, should we discuss a defibrillator, and how often will we reassess that decision?
  3. 3.Would genetic testing be useful for me, and which family members should be screened?
  4. 4.What types and intensity of exercise are reasonable for me?
  5. 5.Which changes in my symptoms would mean my treatment needs to be adjusted?

Last reviewed • Oct 2026

Educational content, not medical advice.